TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Vifor Pharma Nordiska AB
Closing information (x1000 EUR)
Closing information | 2024/06 | 2023/06 | 2021/12 |
Turnover |
29,070
|
36,859
|
23,848 |
Financial expenses |
82
|
120
|
72 |
Earnings before taxes |
2,308
|
666
|
701 |
EBITDA |
2,308
|
807
|
791 |
Total assets |
33,283
|
21,100
|
25,868 |
Current assets |
33,275
|
21,077
|
25,813 |
Current liabilities |
17,243
|
7,389
|
10,617 |
Equity capital |
5,917
|
3,958
|
4,006 |
- share capital |
18
|
17
|
20 |
Employees (average) |
38
|
46
|
40 |
Financial ratios
Fiscal year | 2024/06 | 2023/06 | 2021/12 |
Solvency |
17.8%
|
18.8%
|
15.5% |
Turnover per employee |
765
|
801
|
596 |
Profit as a percentage of turnover |
7.9%
|
1.8%
|
2.9% |
Return on assets (ROA) |
7.2%
|
3.7%
|
3.0% |
Current ratio |
193.0%
|
285.2%
|
243.1% |
Return on equity (ROE) |
39.0%
|
16.8%
|
17.5% |
Change turnover |
-9,192
|
16,176
|
1,764 |
Change turnover % |
-24%
|
78%
|
8% |
Chg. No. of employees |
-8
|
6
|
2 |
Chg. No. of employees % |
-17%
|
15%
|
5% |
Total value of public sale
Fiscal year | 2024/06 | 2023/06 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.